Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro.
A Cantin, D E Woods
A Cantin, D E Woods
Published January 1, 1993
Citation Information: J Clin Invest. 1993;91(1):38-45. https://doi.org/10.1172/JCI116196.
View: Text | PDF
Research Article Article has an altmetric score of 3

Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro.

  • Text
  • PDF
Abstract

Myeloperoxidase, in the presence of noncytotoxic concentrations of H2O2, was used to induce cytotoxicity to the lung epithelial cell line, AKD. When the cationic aminoglycosides, tobramycin and gentamicin were added to the cells in the presence of myeloperoxidase and H2O2, cytotoxicity was completely inhibited. In addition, tobramycin prevented cytotoxicity induced by cystic fibrosis sputum and H2O2. Protection against myeloperoxidase and H2O2 was also observed with the thioether-containing antibiotics, ticarcillin and ceftazidime, but at higher concentrations than with the aminoglycosides. Analysis of spectral properties, dimethylsulfoxide-mediated reduction, and ethyl acetate/NaCl partitioning, demonstrated that aminoglycosides converted HOCl to hydrophilic noncytotoxic chloramines, but were unable to prevent the oxidation of sulfhydryls and methionine by HOCl. In contrast, ticarcillin and ceftazidime were highly effective inhibitors of HOCl-mediated sulfhydryl and methionine oxidation. These results suggest that aminoglycosides protect lung epithelial cells against myeloperoxidase-dependent oxidant injury by binding to anionic cell surfaces and converting HOCl to hydrophilic noncytotoxic chloramines, whereas penicillins and cephalosporins are potent HOCl scavengers capable of protecting critical extracellular molecules against oxidation.

Authors

A Cantin, D E Woods

×

Total citations by year

Year: 2024 2022 2020 2015 2014 2013 2012 2011 2010 2009 2007 2005 2003 2002 2000 1999 1998 1997 1995 1994 1993 Total
Citations: 1 1 2 1 2 1 2 1 1 2 1 2 6 2 3 1 2 2 5 2 1 41
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (41)

Title and authors Publication Year
The vacuolar anti-Pseudomonal activity of neutrophil primary granule peptidyl-arginine deiminase enzymes.
Baird R, Yusuf A, Forde L, Pohl K, Kavanagh K, Fitzpatrick F, Gogoi D, Reeves EP
Frontiers in immunology 2024
Hypochlorous Acid Chemistry in Mammalian Cells—Influence on Infection and Role in Various Pathologies
Andrés CM, Pérez de la Lastra JM, Juan CA, Plou FJ, Pérez-Lebeña E
International journal of molecular sciences 2022
Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis
K McQuillan, F Gargoum, MP Murphy, OJ McElvaney, NG McElvaney, EP Reeves
Frontiers in pharmacology 2020
Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis
G Cabrini, A Rimessi, M Borgatti, I Lampronti, A Finotti, P Pinton, R Gambari
Frontiers in immunology 2020
Hodson and Geddes' Cystic Fibrosis, Fourth Edition
S Chotirmall, M Murray, K Molloy, N McElvaney
Hodson and Geddes' Cystic Fibrosis, Fourth Edition 2015
Spontaneous cystogenesis of toxoplasma gondii in feline epithelial cells in vitro
RM de Muno, MA Moura, LC de Carvalho, SH Seabra, HS Barbosa
Folia Parasitologica 2014
Candidate Markers Associated with the Probability of Future Pulmonary Exacerbations in Cystic Fibrosis Patients
G Wojewodka, JB de Sanctis, J Bernier, J Bérubé, HG Ahlgren, J Gruber, J Landry, LC Lands, D Nguyen, S Rousseau, A Benedetti, E Matouk, D Radzioch, E Gulbins
PloS one 2014
Anti-inflammatory effects of tobramycin and a copper-tobramycin complex with superoxide dismutase-like activity
M Gziut, HJ MacGregor, TG Nevell, T Mason, D Laight, JK Shute
British Journal of Pharmacology 2013
Effects of ceftriaxone on ischemia/reperfusion injury in rat brain
M Altaş, S Meydan, M Aras, N Yılmaz, KT Ulutaş, HM Okuyan, A Nacar
Journal of Clinical Neuroscience 2012
Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection
M Alhariri, A Omri
Antimicrobial agents and chemotherapy 2012
The Cystic Fibrosis Neutrophil: A Specialized Yet Potentially Defective Cell
E Hayes, K Pohl, NG McElvaney, EP Reeves
Archivum Immunologiae et Therapiae Experimentalis 2011
Hypercapnic Acidosis Reduces Oxidative Reactions in Endotoxin-induced Lung Injury
AD Nichol, DF OʼCronin, F Naughton, N Hopkins, J Boylan, P McLoughlin
Anesthesiology 2010
Nephrotoxicity Reduction by Fixed Dose Combination of Cephalosporins and Aminoglycosides in Mus musculus Mice
VK Dwivedi, M Chaudhary, A Soni, SM Shrivastava
Asian Journal of Biochemistry 2009
FIXED-DOSE COMBINATION OF CEFEPIME PLUS AMIKACIN (POTENTOX) INHIBITS PNEUMONIA INFECTION
VK Dwivedi, A Soni, M Chaudhary, CP Singh, SM Shrivastava
Experimental Lung Research 2009
Ceftazidime improves hemodynamics and oxygenation in ovine smoke inhalation injury and septic shock
MO Maybauer, DM Maybauer, JF Fraser, LD Traber, M Westphal, RA Cox, R Huda, YY Nakano, P Enkhbaatar, HK Hawkins, DN Herndon, DL Traber
Intensive Care Medicine 2007
GENTAMICIN IMPROVES HEMODYNAMICS IN OVINE SEPTIC SHOCK AFTER SMOKE INHALATION INJURY
MO Maybauer, DM Maybauer, LD Traber, M Westphal, P Enkhbaatar, N Morita, JM Jodoin, JP Heggers, DN Herndon, DL Traber
Shock 2005
Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage
N Morimoto, M Shimazawa, T Yamashima, H Nagai, H Hara
Brain Research 2005
In vitroinhibition of human neutrophil histotoxicity by ambroxol: evidence for a multistep mechanism
L Ottonello, N Arduino, M Bertolotto, P Dapino, M Mancini, F Dallegri
British Journal of Pharmacology 2003
Endotoxin neutralization and anti-inflammatory effects of tobramycin and ceftazidime in porcine endotoxin shock
G Goscinski, M Lipcsey, M Eriksson, A Larsson, E Tano, J Sjölin
Critical Care 2003
Oxidative Stress and Disease: Significance or Triviality?
B Morrissey, A der Vliet, J Eiserich, C Cross
Oxidative Stress and Disease: Significance or Triviality? 2003
Lung Biology in Health and Disease
N Zamel
Lung Biology in Health and Disease: Experimental Models and Therapeutic Potential 2003
Antimicrobial Susceptibility and Synergistic Activity of Meropenem Against Gram-Negative Non-Fermentative Bacteria Isolated from Cystic Fibrosis Patients
S Campana, G Taccetti, S Farina, N Ravenni, MD Martino
Journal of chemotherapy (Florence, Italy) 2003
Inhaled Tobramycin (TOBI??): A Review of its Use in the Management of Pseudomonas aeruginosa Infections in Patients with Cystic Fibrosis
SM Cheer, J Waugh, S Noble
Drugs 2003
Oxygen consumption and electron spin resonance studies of free radical production by alveolar cells exposed to anoxia: inhibiting effects of the antibiotic ceftazidime
A Mouithys-Mickalad, M Mathy-Hartert, G Du, F Sluse, C Deby, M Lamy, G Deby-Dupont
Redox Report 2002
Aminoglycosides as substrates and inhibitors of peroxidases: a possible role of these antibiotics against myeloperoxidase-dependent cytotoxicity
Anita Lorrai, Alessandra Padiglia, Rosaria Medda, Andrea Bellelli, Alessandro Arcovito, Giovanni Floris
Journal of Protein Chemistry 2002
Myeloperoxidase and protein oxidation in cystic fibrosis
D Torre, G Ferrario, F Speranza, A Orani, GP Fiori, C Zeroli
American journal of physiology. Lung cellular and molecular physiology 2000
Multiple Combination Bactericidal Antibiotic Testing for Patients with Cystic Fibrosis Infected with Burkholderia cepacia
SD Aaron, W Ferris, DA Henry, DP Speert, NO MacDONALD
American journal of respiratory and critical care medicine 2000
First Steps in the Oxidation of Sulfur-Containing Amino Acids by Hypohalogenation: Very Fast Generation of Intermediate Sulfenyl Halides and Halosulfonium Cations
XL Armesto, MC L, MI Fernández, MV Garcı́a, JA Santaballa
Tetrahedron 2000
Cefoperazone Prevents the Inactivation of α1-Antitrypsin by Activated Neutrophils
F Dallegri, P Dapino, N Arduino, M Bertolotto, L Ottonello
Antimicrobial agents and chemotherapy 1999
Myeloperoxidase autoantibodies distinguish vasculitis mediated by anti-neutrophil cytoplasm antibodies from immune complex disease in MRL/Mp-lpr/lprmice: a spontaneous model for human microscopic angiitis
JM Harper, S Thiru, CM Lockwood, A Cooke
European Journal of Immunology 1998
Oxidant-scavenging activities of beta-lactam agents
R Carreer, G Deby-Dupont, C Deby, L Jadoul, M Mathy
European Journal of Clinical Microbiology & Infectious Diseases 1998
Pseudomonas aeruginosa and cystic fibrosis: Antibiotic therapy and the science behind the magic
NE Macdonald
The Canadian Journal of Infectious Diseases 1997
Prevention of Peroxynitrite-Dependent Tyrosine Nitration and Inactivation of α 1 -Antiproteinase by Antibiotics
M Whiteman, B Halliwell
Free Radical Research 1997
Oxidation of methionyl residues in proteins: Tools, targets, and reversal
W Vogt
Free radical biology & medicine 1995
Invited Review: Cell Damage in Inflammatory and Infectious Sites Might Involve A Coordinated “Cross-Talk” Among Oxidants, Microbial Haemolysins and Ampiphiles, Cationic Proteins, Phospholipases, Fatty Acids, Proteinases and Cytokines (An Overview)
I Ginsburg, R Kohen
Free Radical Research 1995
Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime
M Mathy-Hartert, G Deby-Dupont, C Deby, L Jadoul, A Vandenberghe, M Lamy
Mediators of Inflammation 1995
Myeloperoxidase and eosinophil cationic protein in serum and sputum during antibiotic treatment in cystic fibrosis patients with Pseudomonas aeruginosa infection
B Niggemann, T Stiller, K Magdorf, U Wahn
Mediators of Inflammation 1995
Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis
LS Engel, MC Callegan, JA Hobden, JJ Reidy, JM Hill, RJ O'callaghan
Current Eye Research 1995
Taurine modulation of hypochlorous acid-induced lung epithelial cell injury in vitro. Role of anion transport
AM Cantin
Journal of Clinical Investigation 1994
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal
Advances in Pharmacology 1994
Dual-action inhibitors of proteolytic enzymes: potential therapeutic agents for cystic fibrosis and related ailments
WC Groutas, H Huang, R Venkataraman, N Houser-Archield, JB Epp
Bioorganic & Medicinal Chemistry 1993

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 5 patents
12 readers on Mendeley
See more details